The relationships between PD-L1 expression, CD8+ TILs and clinico-histomorphological parameters in malignant melanomas

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2015 · 8.1K citations · Full text

Life Sciences, Oncology, Pharmacotherapy +17

Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy

Janis M. Taube, Alison Klein, Julie R. Brahmer et al. · Clinical Cancer Research · 2014 · 2.3K citations · Full text

Medicine, Immunology, Oncology +17

Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape

Janis M. Taube, Robert A. Anders, Geoffrey D. Young et al. · Science Translational Medicine · 2012 · 2.1K citations

Life Sciences, Immunology, Oncology +14

EGFR exon 20 insertion A763-Y764insFQEA and response to erlotinib-letter

National University of Singapore · 2013 · 1.9K citations

Medicine, Molecular Biology, Oncology +14

Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

Mojgan Ahmadzadeh, Laura A. Johnson, Bianca Heemskerk et al. · Blood · 2009 · 1.8K citations · Full text

Medicine, Immunology, Oncology +12